Abstract:Uridine 5′-diphosphoglucose (UDP-G) as a preferential agonist, but also other UDP-sugars, such as UDP galactose, function as extracellular signaling molecules under conditions of cell injury and apoptosis. Consequently, UDP-G is regarded to function as a damage-associated molecular pattern (DAMP), regulating immune responses. UDP-G promotes neutrophil recruitment, leading to the release of pro-inflammatory chemokines. As a potent endogenous agonist with the highest affinity for the P2Y 14 receptor (R), it accomplishes an exclusive relationship between P2Y 14 Rs in regulating inflammation via cyclic adenosine monophosphate (cAMP), nod-like receptor protein 3 (NLRP3) inflammasome, mitogen-activated protein kinases (MAPKs), and signal transducer and activator of transcription 1 (STAT1) pathways. In this review, we initially present a brief introduction into the expression and function of P2Y 14 Rs in combination with UDP-G. Subsequently, we summarize emerging roles of UDP-G/P2Y 14 R signaling pathways that modulate inflammatory responses in diverse systems, and discuss the underlying mechanisms of P2Y 14 R activation in inflammation-related diseases. Moreover, we also refer to the applications as well as effects of novel agonists/antagonists of P2Y 14 Rs in inflammatory conditions. In conclusion, due to the role of the P2Y 14 R in the immune system and inflammatory pathways, it may represent a novel target for anti-inflammatory therapy.

UDP-glucose sensing P2Y 14 R: A novel target for inflammation